RAM
SWTX

Readystate Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Readystate Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77,100
Closed -$2.79M – 734
2024
Q4 		$2.79M Buy
+77,100
New +$2.69M 0.09% 241

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Readystate Asset Management's SWTX Position: Q1 2025 in Review

Readystate Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q1 2025, closing a stake of 77,100 shares — an estimated $2.79M sold.

Readystate Asset Management first reported a position in SWTX in Q4 2024 and held it in 1 quarter. The position peaked at $2.79M in Q4 2024. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

  • Readystate Asset Management reported no remaining SpringWorks Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Readystate Asset Management sold 77,100 SpringWorks Therapeutics shares in Q1 2025, an estimated $2.79M.
  • Readystate Asset Management first reported a position in SpringWorks Therapeutics in Q4 2024 and held it in 1 quarter.
  • Readystate Asset Management's SpringWorks Therapeutics position peaked at $2.79M in Q4 2024.
  • 306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on Readystate Asset Management's 13F filing for Q1 2025, filed 6 May 2025.